Advertisement

Topics

Atreca to Present at 2018 American Association for Cancer Research Annual Meeting

17:00 EDT 14 Mar 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Research Supports an Important Role for Antibodies in the Tumor-Fighting Immune Responses Observed in Patients Following Cancer Immunotherapies Atreca, Inc., a biotechnology company focused on developing novel therape...

Other Sources for this Article

Atreca, Inc.
Susan Berland
EVP and Chief Financial Officer
info@atreca.com
or
Media:
Justin Jackson, 212-213-0006, ext. 327
jjackson@burnsmc.com
or
Investors:
John Grimaldi, 212-213-0006, ext. 362
jgrimaldi@burnsmc.com

NEXT ARTICLE

More From BioPortfolio on "Atreca to Present at 2018 American Association for Cancer Research Annual Meeting"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...